{"id": "1351955657545625604", "creation": 1611166321.0, "user_id": "61857711", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Johnson &amp; Johnson provides good news for their #Covid19 #vaccine candidate. Data from a Phase I/II trial shows safety in a group of people 65 and older, as well as 18-55. The company plans to announce topline Phase 3 data at the end of January.\nhttps://t.co/tjvzL2HeGN", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}